Experimental Prostate Cancer Vaccine Shows Promise

Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data presented by researchers at the Kimmel Cancer Center at Jefferson.

Meningitis B Vaccine Shows Promise

Researchers have concluded a Phase II study of an investigational vaccine against group B Neisseria meningitidis, which shows promising results.

Pertussis Vaccine Loses Power Over Time

A new study suggests that protection from the childhood series of the diphtheria, tetanus and acellular pertussis vaccine fades within five years of the final dose.

CDC Preparing Vaccine for New Swine Flu

Despite only 29 human cases of the new strain of swine flu in the past two years, the Centers for Disease Control and Prevention (CDC) is preparing an H3N2 candidate vaccine, and clinical trials are being planned for this year.

Malaria Vaccine Close to Reality

Preliminary results from a Phase III clinical trial in Africa showed that a malaria vaccine, known as RTS,S, cut the number of malaria cases by 50 percent in a 12-month period following vaccination.